New single-concentration acetaminophen products added to PediaCare, Little Remedies lines
IRVINGTON, N.Y. — Prestige Brands on Thursday announced the launch of its new PediaCare and Little Remedies single-concentration acetaminophen products.
The new standard concentration liquid acetaminophen products for infants and children under 2 years of age will be 160 mg/5 mL.
“The voluntary changes to single-concentration acetaminophen dosing demonstrate the continued commitment to accuracy, safety and innovation from PediaCare and Little Remedies," Prestige VP over-the-counter products Albert Hwang said.
Both PediaCare and Little Remedies also will offer additional product enhancements, including age-appropriate dosing devices. Infant products now will contain a special dosing syringe and flow restrictors on the bottles. Children’s products, for ages 2 to 11 years, will have the bottles with flow restrictors and will continue to contain dosing cups. Both infant and children’s formulations will continue to have weight-based instructions on the package as well.
“While the new single-concentration for PediaCare and Little Fevers infants’ and children’s acetaminophen products will be among the first brands to hit store shelves, parents should know that there will be a ’transition period’ during which the existing concentrated infant products and the new standard-strength acetaminophen infant PediaCare and Little Fevers products may be on store shelves simultaneously,” Hwang said. “The new infant formula is less concentrated, and the dose is therefore more than in the older infant formulation. And while reading and following package directions is always recommended to obtain accurate dosing instructions, it will be even more important while the two concentrations are available."
The new PediaCare and Little Remedies products will be available this month at pharmacies nationwide. To learn more about the new acetaminophen dosing system for PediaCare or Little Remedies, visit PediaCare.com or LittleRemedies.com.
GMDC’s SEC format will be featured at the 2011 HBW Conference
COLORADO SPRINGS, Colo. — Global Market Development Center on Thursday announced that its 2011 HBW Conference, which will be held in Phoenix from Sept. 9 to 12, will feature the Senior Executive Conference for the sixth time.
The SEC format helps foster business development opportunities and consists of 40-minute appointments that took place in more relaxed venues than the traditional controlled casual conferences.
This year, as many as 60 member companies have registered to participate, GMDC said.
“The SEC meetings have proven to be an excellent forum to exchange strategies and tactics with our key vendor partners," Meijer VP drug store Nat Love said. "We have participated in the SEC meetings every year and use them for last-minute fourth-quarter opportunities and for setting the stage for the upcoming year.”
PharmaCline announces plans to launch antibiotic
SIOUX FALLS, S.D. — PharmaCline on Thursday announced it has secured the worldwide rights for drug delivery technology and existing antibiotic products from Phillips Co. that will enable production of a well-tolerated and broad-spectrum topical antibiotic.
According to the company, many people have unwanted allergic responses and localized dermatitis from ingredients in conventional triple antibiotic products. No such problems have been reported to date with the PharmaCline products, the company stated, due to the use of tetracycline and its historically safe profile. Tests show that the new antibiotic product is effective against topical Gram-positive and Gram-negative bacteria.
PharmaCline currently is in the process of securing capital to support upcoming U.S. and international product launches. Human field studies are ongoing, as well as preclinical work at a leading pharmacy school in the United States, the company stated. Products initially will be available online and then will be launched into specific U.S. markets with more traditional campaigns directed at healthcare providers and pharmacies.